Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06051539 · ClinicalTrials.gov registry record · NA

Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation

A NA study of Chronic Stroke, sponsored by MedRhythms.

Active
Registry status
NA
Development phase
234
Enrollment target
1
Study location

NCT06051539 is a NA study of Chronic Stroke that is active but no longer recruiting, run by MedRhythms. The registered enrollment target is 234 participants, above the 32-participant average among 20 other Chronic Stroke trials with a reported enrollment target (631% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06051539, a NA study of Chronic Stroke, is active but no longer recruiting, sponsored by MedRhythms.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
234 participants
Enrollment target
1
Study location

Study Summary

The purpose of this trial is to assess engagement, efficacy, durability, and impact on health care resource utilization of MR-001 in persons with chronic stroke who have a gait deficit after in-home/community use.

Conditions Studied

Interventions

  • DEVICE MR-001

Study Locations (1)

Maine

  • Curavit Clinical Research - DECENTRALIZED CLINICAL TRIAL - Portland

Trial Details

FieldValue
Enrollment Target 234 participants
Start Date 2023-10-10
Est. Completion 2025-12
Phase NA

Sponsor

MedRhythms

4 total trials

What the Registry Record Tells You About NCT06051539

The ClinicalTrials.gov registry entry for NCT06051539 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 32-participant average among 20 other Chronic Stroke trials with a reported enrollment target (631% higher). The listed sponsor is MedRhythms, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 1 intervention - of which MR-001 is the first listed.

NCT06051539 reports 1 study location spanning 1 distinct geographic area - top geographies include Maine.

Frequently Asked Questions

What is clinical trial NCT06051539 about?

NCT06051539 is a clinical study titled "Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation". The purpose of this trial is to assess engagement, efficacy, durability, and impact on health care resource utilization of MR-001 in persons with chronic stroke who have a gait deficit after in-home/community use.

What is the current status of trial NCT06051539?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 234 participants. The study started on 2023-10-10. Estimated completion is 2025-12.

What conditions does trial NCT06051539 study?

This clinical trial studies the following conditions: Chronic Stroke.

What interventions are being tested in trial NCT06051539?

The interventions under investigation include: MR-001 (DEVICE).

Who is sponsoring clinical trial NCT06051539?

This trial is sponsored by MedRhythms, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06051539 being conducted?

This trial has 1 study location across Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.